Company news
Valirx Plc (LSE:VAL) news
Valirx Plc news releases on 6ix. Latest, Nov 22, 2024: Inaphaea award of HEIF Funding and PhD sponsorship
Press releases — page 2
Inaphaea award of HEIF Funding and PhD sponsorship
November 22, 2024
Update on proposed sub-license of VAL401
November 20, 2024
Contract Award
November 19, 2024
First Sale of New Product Line
November 18, 2024
Directorate Change
October 18, 2024
Investor Webinar
October 14, 2024
Inaphaea Co-Marketing Agreement
October 7, 2024
Investor Evening
September 9, 2024
Directorate Changes
July 25, 2024
Proposed Director Appointment
July 3, 2024
Inaphaea Contract Award
June 17, 2024
Business Update
May 20, 2024
Further re Final Results
May 16, 2024
Final Results and Notice of AGM
May 15, 2024
Evaluation Agreement with Imperial College London
March 21, 2024
Board Re-structuring and update on requisition
March 19, 2024
Shareholder Requisition Notice
March 4, 2024
Proposed Appointment of Non-Executive Director
March 4, 2024
Further re Shareholder Requisition Notice
February 13, 2024
Agreement with Dundee Uni and Project Initiation
February 12, 2024
Change of Broker
January 19, 2024
Result of GM, Issue of Equity
January 4, 2024
Result of Retail Offer, Subscription
December 19, 2023
Posting of Circular, Notice of GM and Ops Review
December 15, 2023
Retail Offer
December 13, 2023
Conditional Fundraise, Notice of General Meeting
December 13, 2023
ValiRx strikes deal with Ambrose Healthcare to license late-stage cancer treatment
December 6, 2023
Agreement to License VAL401 to Ambrose Healthcare
December 5, 2023
Evaluation Agreement with StingRay Bio
November 10, 2023
Statement re Share Price Movement
October 6, 2023
Operational Review
September 28, 2023
Collaborative Services Agreement
August 14, 2023
Inaphaea BioLabs secures first external contract
July 19, 2023
Virtual AGM Access
June 20, 2023
Inaphaea BioLabs Operational Update
June 19, 2023
Conclusion of Hokkaido Evaluation Agreement
June 16, 2023
Asset Purchase – Imagen Therapeutics
June 14, 2023
Expanded agreement with University of Barcelona
June 7, 2023
Notice of Results and Investor Webinar
May 26, 2023
Valaris Announces Appointment of New ARO Dril...
May 1, 2023
Valaris Provides Fleet Status Report
May 1, 2023
Valaris Reports First Quarter 2023 Results
May 1, 2023
Quarterly Operational Update
March 31, 2023
Incorporation of Inaphaea BioLabs Limited
March 1, 2023
Second Price Monitoring Extn
February 24, 2023
Price Monitoring Extension
February 24, 2023
Operational Update
January 31, 2023
Broker Offer Results
January 17, 2023
Launch of Broker Offer
January 13, 2023
Issue of Equity & Proposed Broker Offer
January 13, 2023